- 专利标题: Benzodiazepine derivatives
-
申请号: US13826181申请日: 2013-03-14
-
公开(公告)号: US08802667B2公开(公告)日: 2014-08-12
- 发明人: Wei Li , Nathan Elliott Fishkin , Robert Yongxin Zhao , Michael Louis Miller , Ravi V. J. Chari
- 申请人: Wei Li , Nathan Elliott Fishkin , Robert Yongxin Zhao , Michael Louis Miller , Ravi V. J. Chari
- 申请人地址: US MA Waltham
- 专利权人: ImmunoGen, Inc.
- 当前专利权人: ImmunoGen, Inc.
- 当前专利权人地址: US MA Waltham
- 代理机构: McCarter & English, LLP
- 代理商 Steven G. Davis; Yu Lu
- 主分类号: C07D519/00
- IPC分类号: C07D519/00 ; A61K31/5517 ; A61K31/55 ; A61P35/00 ; A61K47/48 ; C07K5/103 ; C07D498/04 ; A61K38/07 ; A61K45/06 ; C07D487/04 ; C07K16/28
摘要:
The invention relates to novel benzodiazepine derivatives with antiproliferative activity and more specifically to novel benzodiazepines of formula (I) and (II), in which the diazepine ring (B) is fused with a heterocyclic ring (CD), wherein the heterocyclic ring is bicyclic or a compound of formula (III), in which the diazepine ring (B) is fused with a heterocyclic ring (C), wherein the heterocyclic ring is monocyclic. The invention provides cytotoxic dimers of these compounds. The invention also provides conjugates of the monomers and the dimers. The invention further provides compositions and methods useful for inhibiting abnormal cell growth or treating a proliferative disorder in a mammal using the compounds or conjugates of the invention. The invention further relates to methods of using the compounds or conjugates for in vitro, in situ, and in vivo diagnosis or treatment of mammalian cells, or associated pathological conditions.
公开/授权文献
- US20130302357A1 NOVEL BENZODIAZEPINE DERIVATIVES 公开/授权日:2013-11-14
信息查询